Pulmonary surfactant camouflage lipid nanoparticles for efficient mRNA lung delivery
Open Access
- 8 June 2026
- journal article
- Published by Springer Nature in Signal Transduction and Targeted Therapy
- Vol. 11 (1)
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapyNature Communications, 2024
- Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccinationScience Immunology, 2022
- Advances in COVID-19 mRNA vaccine developmentSignal Transduction and Targeted Therapy, 2022
- Pulmonary surfactant and drug delivery: Focusing on the role of surfactant proteinsJournal of Controlled Release, 2018
- Respiratory epithelial cells orchestrate pulmonary innate immunityNature Immunology, 2014